Company Overview and News

 
Donald Trump Is Driving a Rusty Old Ford In the Tesla Era - Bloomberg

2018-03-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
General Motors to Hike EV Bolt Production to Meet Demand

2018-03-09 zacks
General Motors Company (GM - Free Report) announced that it would increase the production of Chevrolet Bolt electric vehicle (EV) to meet growing demand, per Reuters. Additionally, the carmaker asked the U.S. Congress to rethink about the expansion of the tax credit for EV.
Upvote Downvote

 
Kenya Says French Companies to Invest $10 Billion in 12 Projects - Bloomberg

2018-03-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Peugeor car maker PSA makes Malaysian Naza plant its Asean hub

2018-02-26 thestar.com.my
Winning venture: Naza Corp joint group executive chairman SM Nasarudin SM Nasimuddin exchanging documents with Gomes after the signing ceremony witnessed by Prime Minister Datuk Seri Najib Tun Razak. Looking on are Kedah Mentri Besar Datuk Seri Ahmad Bashah Md Hanipah (left) and International Trade and Industry Minister Datuk Seri Mustapa Mohamed.
Upvote Downvote

 
France’s New Layoff Law Triggers Flux in Labor Market - WSJ

2018-02-19 wsj
PARIS—Some of France’s largest employers are seizing on President Emmanuel Macron’s labor-system overhaul to undertake mass layoffs, heralding a sea change for a country that has long coddled its workforce.
Upvote Downvote

 
Penske Automotive (PAG) Q4 Earnings Top Estimates, Up Y/Y

2018-02-09 zacks
Penske Automotive Group, Inc. (PAG - Free Report) recorded adjusted earnings of $1.01 per share in fourth-quarter fiscal 2017 compared with 91 cents a year ago. The bottom line also surpassed the Zacks Consensus Estimate of $1. Including tax benefits, the earnings came in at $3.85.
Upvote Downvote

 
Goodyear (GT) Q4 Earnings & Revenues Beat Estimates, Up Y/Y

2018-02-08 zacks
The Goodyear Tire & Rubber Company (GT - Free Report) reported adjusted earnings per share of 99 cents in comparison to 95 cents in the prior-year quarter. Moreover, the bottom line surpassed the Zack Consensus Estimate of 76 cents. The company reported net loss of $96 million against net income of $561 million in fourth-quarter 2016.
Upvote Downvote

 
O'Reilly (ORLY) Q4 Earnings & Revenues Surpass Estimates

2018-02-08 zacks
O’Reilly Automotive Inc. (ORLY - Free Report) reported adjusted earnings of $2.9 per share in fourth-quarter 2017, beating the Zacks Consensus Estimate of $2.78. The bottom line was $2.59 in the prior-year quarter.
Upvote Downvote

 
Toyota (TM) Q3 Operating Income Surges 54%, Revenues Rise

2018-02-06 zacks
Toyota Motor Corporation’s (TM - Free Report) operating income soared 54% to ¥673.6 billion ($5.96 billion) in third-quarter fiscal 2018 (ended Dec 31, 2017). Also, the Japanese automaker reported net income of ¥970.7 billion ($8.6 billion) in the quarter in comparison to ¥506.8 billion ($4.7 billion) in the prior-year quarter.
Upvote Downvote

 
Cummins (CMI) Q4 Earnings Top Estimates, Guidance Revised

2018-02-06 zacks
Cummins Inc. (CMI - Free Report) reported adjusted earnings of $3.03 per share in fourth-quarter 2017, surpassing the Zacks Consensus Estimate of $2.65. The company’s bottom line was $2.25 in the year-ago quarter.
Upvote Downvote

 
Peugeot 'very open' to alliance in Latin America - CEO

2018-01-18 reuters
Jan 18 (Reuters) - Peugeot SA is “very open” to a potential alliance in Latin America, the chief executive of the French automaker, Carlos Tavares, said during a media briefing on Thursday.
Upvote Downvote

 
PRESS DIGEST- British Business - Jan 9

2018-01-09 reuters
Jan 9 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
Lyft and Aptiv Will Show Off Driverless Ride-Hailing at CES - Bloomberg

2018-01-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Beijing Backs the EV Tortoise - Bloomberg Gadfly

2017-11-30 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Fiat Chrysler Rejects French Diesel Test-Manipulation Claims - Bloomberg

2017-11-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...